Bruker Corp (BRKR): Frank H Laukien , CEO of Bruker Corp purchased 4,174 shares on Jun 14, 2016. The Insider buying transaction was reported by the company on Jun 15, 2016 to the Securities and Exchange Commission. The shares were purchased at $23.95 per share for a total value of $99,958.53 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 15, 2016, Frank H Laukien (CEO) purchased 4,174 shares at $23.95 per share price.On Jun 7, 2016, Joerg C Laukien (director 10% owner) sold 2,000,000 shares at $25.65 per share price.Also, On May 11, 2016, Brenda J Furlong (director) sold 22,600 shares at $27.43 per share price.On May 11, 2016, Wolf-dieter Emmerich (director) sold 21,000 shares at $27.35 per share price.
Shares of Bruker Corporation (BRKR) ended Tuesday, Jun 14, 2016 session in red amid volatile trading. The shares closed down -0.41 points or -1.68% at $23.94 with 24,36,564 shares getting traded. Post opening the session at $24.4, the shares hit an intraday low of $23.775 and an intraday high of $24.49 and the price vacillated in this range throughout the day. The company has a market cap of $3,865 M and the number of outstanding shares has been calculated to be 16,14,54,760 shares. The 52-week high of Bruker Corporation is $29.85 and the 52-week low is $15.778.
Company has been under the radar of several Street Analysts.Bruker Corporation is Reiterated by Mizuho to Neutral and the brokerage firm has raised the Price Target to $ 28 from a previous price target of $22 .The Rating was issued on May 5, 2016.Bruker Corporation is Reiterated by Barclays to Overweight and the brokerage firm has raised the Price Target to $ 32 from a previous price target of $30 .The Rating was issued on May 5, 2016.Bruker Corporation is Downgraded by Leerink Partners to Mkt Perform. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 5, 2016.Bruker Corporation is Downgraded by BofA/Merrill to Underperform. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 5, 2016.
Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.